RHS Financial’s ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 UCIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $5.68M | Buy |
150,235
+23,385
| +18% | +$846K | 1.92% | 15 |
|
|
2026
Q2 | $4.13M | Buy |
126,850
+11,478
| +10% | +$392K | 1.67% | 19 |
|
|
2026
Q1 | $3.8M | Sell |
115,372
-1,644
| -1% | -$50K | 1.8% | 18 |
|
|
2025
Q4 | $3.28M | Buy |
117,016
+734
| +0.6% | +$20.2K | 1.6% | 20 |
|
|
2025
Q3 | $3.16M | Buy |
116,282
+2,469
| +2% | +$66.2K | 1.64% | 22 |
|
|
2025
Q2 | $3M | Buy |
113,813
+1,968
| +2% | +$51.3K | 1.7% | 18 |
|
|
2025
Q1 | $2.97M | Sell |
111,845
-1,938
| -2% | -$51.9K | 1.67% | 19 |
|
|
2024
Q4 | $2.88M | Buy |
113,783
+4,304
| +4% | +$111K | 1.49% | 21 |
|
|
2024
Q3 | $2.84M | Sell |
109,479
-17,604
| -14% | -$441K | 1.43% | 19 |
|
|
2024
Q2 | $3.32M | Buy |
127,083
+10,820
| +9% | +$286K | 2.03% | 16 |
|
|
2024
Q1 | $2.97M | Sell |
116,263
-18,402
| -14% | -$451K | 1.73% | 17 |
|
|
2023
Q4 | $3.25M | Buy |
134,665
+7,936
| +6% | +$196K | 2.06% | 16 |
|
|
2023
Q3 | $3.22M | Buy |
126,729
+10,441
| +9% | +$261K | 2.25% | 15 |
|
|
2023
Q2 | $2.73M | Sell |
116,288
-2,131
| -2% | -$50.7K | 2% | 15 |
|
|
2023
Q1 | $2.88M | Sell |
118,419
-7,425
| -6% | -$181K | 2.19% | 15 |
|
|
2022
Q4 | $3.11M | Sell |
125,844
-23,393
| -16% | -$561K | 2.47% | 11 |
|
|
2022
Q3 | $3.39M | Sell |
149,237
-17,338
| -10% | -$410K | 3.01% | 11 |
|
|
2022
Q2 | $4.04M | Sell |
166,575
-11,110
| -6% | -$292K | 3.32% | 9 |
|
|
2022
Q1 | $4.59M | Sell |
177,685
-2,742
| -2% | -$64.4K | 3.38% | 8 |
|
|
2021
Q4 | $3.77M | Buy |
180,427
+245
| +0.1% | +$5.06K | 2.62% | 14 |
|
|
2021
Q3 | $3.61M | Buy |
180,182
+2,711
| +2% | +$52.9K | 2.63% | 13 |
|
|
2021
Q2 | $3.43M | Sell |
177,471
-483
| -0.3% | -$8.97K | 2.56% | 16 |
|
|
2021
Q1 | $3M | Buy |
177,954
+12,036
| +7% | +$200K | 2.51% | 16 |
|
|
2020
Q4 | $2.53M | Buy |
165,918
+6,725
| +4% | +$94.6K | 2.17% | 17 |
|
|
2020
Q3 | $2.12M | Sell |
159,193
-5,532
| -3% | -$72.4K | 2.13% | 17 |
|
|
2020
Q2 | $2.01M | Buy |
164,725
+66,407
| +68% | +$754K | 2.35% | 17 |
|
|
2020
Q1 | $1.08M | Buy |
+98,318
| New | +$1.31M | 1.44% | 26 |
|
RHS Financial's UCIB Position: Q3 2026 in Review
RHS Financial increased its ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 (UCIB) stake by 18% in Q3 2026, buying an estimated $846K and bringing the position to 150,235 shares worth $5.68M. The position accounts for 1.92% of the portfolio, ranked #15.
RHS Financial first reported a position in UCIB in Q1 2020 and has held it in 27 quarters since. 1 fund tracked by Wall St. Rank holds UCIB as of Q3 2026.
- RHS Financial held 150,235 shares of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 worth $5.68M as of Q3 2026.
- RHS Financial bought 23,385 ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 shares in Q3 2026, an estimated $846K.
- ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 made up 1.92% of RHS Financial's portfolio in Q3 2026, its #15 holding.
- RHS Financial first reported a position in ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 in Q1 2020 and has held it in 27 quarters since.
- 1 fund tracked by Wall St. Rank held ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 as of Q3 2026.
Based on RHS Financial's 13F filing for Q3 2026, filed 13 Oct 2026.